Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Relay Therapeutics Inc’s stock clocked out at $4.42, up 2.79% from its previous closing price of $4.30. In other words, the price has increased by $2.79 from its previous closing price. On the day, 1.09 million shares were traded. RLAY stock price reached its highest trading level at $4.42 during the session, while it also had its lowest trading level at $4.255.
Ratios:
To gain a deeper understanding of RLAY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.42 and its Current Ratio is at 18.42. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when PETER J RAHMER bought 32,177 shares for $4.30 per share.
Adams Brian sold 299 shares of RLAY for $1,310 on Dec 27 ’24. The Chief Legal Officer now owns 321,608 shares after completing the transaction at $4.38 per share. On Dec 27 ’24, another insider, Bergstrom Donald A, who serves as the President, R&D of the company, sold 657 shares for $4.38 each. As a result, the insider received 2,878 and left with 520,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 739832896 and an Enterprise Value of -49961324. For the stock, the TTM Price-to-Sale (P/S) ratio is 75.97 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at -4.993 whereas that against EBITDA is 0.128.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $4.01. The 50-Day Moving Average of the stock is -12.23%, while the 200-Day Moving Average is calculated to be -33.08%.
Shares Statistics:
It appears that RLAY traded 1.91M shares on average per day over the past three months and 1951610 shares per day over the past ten days. A total of 166.89M shares are outstanding, with a floating share count of 123.37M. Insiders hold about 26.30% of the company’s shares, while institutions hold 73.17% stake in the company. Shares short for RLAY as of 1734048000 were 12081421 with a Short Ratio of 6.32, compared to 1731628800 on 11611974. Therefore, it implies a Short% of Shares Outstanding of 12081421 and a Short% of Float of 8.75.
